Cardiac Damage and Quality of Life After Aortic Valve Replacement in the PARTNER Trials
Journal of the American College of Cardiology · 2023-02 · 81 (8) · 743-752
DOI: 10.1016/j.jacc.2022.11.059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American College of Cardiology, 2023-02. Verfasst von Philippe Généreux und 21 weiteren Autor:innen. Beteiligte Einrichtung: Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, New Jersey, USA. Electronic address: hilippe.genereux@atlantichealth.org. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis, Heart Valve Prosthesis Implantation. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The extent of extravalvular cardiac damage is associated with increased risk of adverse events among patients with severe aortic stenosis undergoing aortic valve replacement (AVR). OBJECTIVES: The goal was to describe the association of cardiac damage on health status before and after AVR. METHODS: Patients from the PARTNER (Placement of Aortic Transcatheter Valves) 2 and 3 trials were pooled and classified by echocardiographic cardiac damage stage at baseline and 1 year as previously described (stage 0-4). We examined the association between baseline cardiac damage and 1-year health status (assessed by the Kansas City Cardiomyopathy Questionnaire Overall Score [KCCQ-OS]). RESULTS: Among 1,974 patients (794 surgical AVR, 1,180 transcatheter AVR), the extent of cardiac damage at baseline was associated with lower KCCQ scores both at baseline and at 1 year after AVR (P < 0.0001) and with increased rates of a poor outcome (death, KCCQ-OS
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, New Jersey, USA. Electronic address: hilippe.genereux@atlantichealth.org.
- Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, USA; St. Francis Hospital and Heart Center, Roslyn, New York, USA.
- Department of Medicine, Laval University, Quebec City, Quebec, Canada.
- Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, USA; Columbia University Irving Medical Center, New York, New York, USA; Department of Cardiology, Sahlgrenska University Hospital, Gothenb…
- Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
- Edwards Lifesciences, Irvine, California, USA.
Zitieren
APA
Généreux, P., Cohen, D. J., Pibarot, P., Redfors, B., Bax, J. J., Zhao, Y., Prince, H., Makkar, R. R., Kapadia, S., Thourani, V. H., Mack, M. J., Nazif, T. M., Lindman, B. R., Babaliaros, V., Russo, M., McCabe, J. M., Gillam, L. D., Alu, M. C., Hahn, R. T., …, & Arnold, S. V. (2023). Cardiac Damage and Quality of Life After Aortic Valve Replacement in the PARTNER Trials. Journal of the American College of Cardiology, 81(8), 743-752. https://doi.org/10.1016/j.jacc.2022.11.059
Vancouver
Généreux P, Cohen DJ, Pibarot P, Redfors B, Bax JJ, Zhao Y, et al. Cardiac Damage and Quality of Life After Aortic Valve Replacement in the PARTNER Trials. Journal of the American College of Cardiology. 2023;81(8):743-752. doi:10.1016/j.jacc.2022.11.059
BibTeX
@article{Gnreux2023,
author = {Généreux, Philippe and Cohen, David J and Pibarot, Philippe and Redfors, Björn and Bax, Jeroen J and Zhao, Yanglu and Prince, Heather and Makkar, Raj R and Kapadia, Samir and Thourani, Vinod H and Mack, Michael J and Nazif, Tamim M and Lindman, Brian R and Babaliaros, Vasilis and Russo, Mark and McCabe, James M and Gillam, Linda D and Alu, Maria C and Hahn, Rebecca T and Webb, John G and Leon, Martin B and Arnold, Suzanne V},
title = {Cardiac Damage and Quality of Life After Aortic Valve Replacement in the PARTNER Trials},
journal = {Journal of the American College of Cardiology},
year = {2023},
volume = {81},
number = {8},
pages = {743--752},
doi = {10.1016/j.jacc.2022.11.059}
}
EUVIMED